Patent infringement questions often start with a practical business problem, not a courtroom brief. A company is preparing to launch a product, a competitor sends a letter, a customer asks whether a feature is “safe,” or a founder notices a patent number on someone else’s packaging and wonders what it covers. In those moments, the answer rarely comes from a quick keyword search or a side-by-side look at two products.
In general terms, patent infringement turns on claims—the numbered legal definitions at the end of a patent—not on a patent’s title, abstract, marketing language, or even the drawings alone. Under 35 U.S.C. § 271, infringement can arise from making, using, offering to sell, selling, or importing a patented invention in the United States. And because infringement analysis is claim-specific and fact-intensive, the question is usually whether a product includes every element of at least one asserted claim, either literally or sometimes through the doctrine of equivalents, rather than whether the product seems generally similar to the patented idea. The USPTO’s patent search tools and Patent Public Search make it easier to locate patents and published applications, but translating that material into risk analysis is another step entirely.
In this post you’ll learn how to evaluate whether a product may infringe a patent, what documents matter most, where companies often misread the issue, and when an attorney’s technical and litigation experience can make a major difference. If you want broader context first, our guide to the bigger picture of patent disputes walks through claims, products, damages, and common defense themes.
<aside> 💡 Scroll to the bottom for every post in this series.
</aside>
A patent does not give its owner a general right over a concept. It gives rights defined by the patent’s claims. The USPTO explains that the claims define the invention’s legal boundaries, and claim language is what matters when courts analyze infringement. The claims, specification, and prosecution history together often form the core “intrinsic evidence” used in claim construction, which is the process of determining what the claims mean in context. That is one reason a product that looks different can still create risk, while a product that looks similar may not.
This also helps explain why non-lawyers often overestimate or underestimate exposure:
The stakes can be substantial. The 2025 Lex Machina Patent Litigation Report described a rebound in U.S. patent filings during 2024 and reported more than $4.3 billion in damages awarded, with notable growth in design patent lawsuits. Separately, the AIPLA’s 2025 Economic Survey continues to be widely cited for the high cost of patent litigation, and publicly quoted summaries of the prior survey show six- and seven-figure median litigation costs depending on the amount at risk. Even when a dispute never reaches trial, the cost of getting the analysis wrong can be significant.
The first step is identifying the actual patent or patents at issue. That sounds obvious, but it is common to see internal teams reviewing the wrong family member, an expired patent, a foreign counterpart, or a published application instead of an issued U.S. patent.
A more careful review usually looks at: